Subsite variation of HPV-related p16-expression in oropharynx cancer: Incidence and prognostic impact in a population-based DAHANCA cohort 1986–2020

Subsite variation of HPV-related p16-expression in oropharynx cancer: Incidence and prognostic impact in a population-based DAHANCA cohort 1986–2020

p16-expression are implemented in the TNM8 classification of oropharyngeal cancer (OPSCC). Based on a nationwide cohort, we provide a detailed description of subsite variation in the age-standardised incidence-rates of OPSCC alongside an evaluation of the prognostic impact of p16-expression accordin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pernille Lassen, Jan Alsner, Hanne Primdahl, Christina Caroline Plaschke, Christian Maare, Jørgen Johansen, Maria Andersen, Mohammad Farhadi, Jens Overgaard
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2025-08-01
Series:	Acta Oncologica
Subjects:	Oropharyngeal cancer, HPV, subsite, TNM8 classification, radiotherapy, prognosis
Online Access:	https://medicaljournalssweden.se/actaoncologica/article/view/44027
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Patient experience and shared decision-making in HPV-positive oropharyngeal cancer: A systematic review of qualitative and quantitative evidence
by: Pierluigi Bonomo, et al.
Published: (2025-11-01)

Neoadjuvant sintilimab and chemotherapy followed by transoral surgery for HPV-positive resectable oropharyngeal cancer: a single-arm, two-centre, phase 2 trialResearch in context
by: Shida Yan, et al.
Published: (2025-08-01)

Response sensitivity to bacteriophages of Staphylococcus aureus strains isolated from the microbiota of the oropharynx in children of Irkutsk
by: E. V. Grigorova, et al.
Published: (2017-09-01)

HPV prevalence and genotype distribution among women in Sanming, China: a retrospective analysis before large-scale vaccination
by: Xiang Jiang, et al.
Published: (2025-07-01)

Southern Vietnamese women’s views on HPV vaccination, cervical cancer screening, and HPV self-sampling
by: Minh Tung Phung, et al.
Published: (2025-08-01)

The HPV vaccine—What the family practitioner needs to know
by: Franco Guidozzi
Published: (2008-08-01)

Molecular Features of HPV-Independent Cervical Cancers
by: Luca Giannella, et al.
Published: (2025-07-01)

Anogenital high-risk HPV prevalence and screening considerations in female transplant recipients: a cross-sectional study
by: Christoph Hillen, et al.
Published: (2025-07-01)

Utilizing tumor deposit count as a stratification criterion in revising TNM staging system for patients with colorectal cancer: a nomogram review study
by: Lifei Zhang, et al.
Published: (2025-08-01)

Knowledge and attitudes toward HPV, cervical cancer and HPV vaccine among healthcare providers in Ahvaz, Southwest Iran
by: Abdolhussein Shakurnia, et al.
Published: (2025-07-01)

Clinicopathological analysis of HPV‐related and non‐HPV‐related oral/oropharyngeal squamous cell carcinoma
by: WANG Xiaoling, et al.
Published: (2023-06-01)

Correlation between clinical features, medical history, and lifestyle factors with colorectal cancer stage
by: Asma Sghaier, et al.
Published: (2025-08-01)

Prevalence of HPV/p16+ infection among oropharyngeal squamous cell carcinoma patients in a tertiary care centre in Southern India
by: V. Jawahar, et al.
Published: (2023-10-01)

Photodynamic therapy in a patient with hpv-associated lsil of the cervice (clinical case)
by: E. V. Filonenko, et al.
Published: (2022-11-01)

Provider perspectives on HPV vaccine hesitancy in the post-COVID-19 era
by: Thao N. Hoang, et al.
Published: (2025-12-01)

EDUKASI PENCEGAHAN KANKER SERVIKS SEDARI DINI DENGAN VAKSINASI HPV BAGI SISWA SDN 44 PADANG
by: Shelvy Haria Roza, et al.
Published: (2025-03-01)

Analysis of factors driving HPV vaccination coverage and associated cost savings in the united States
by: Shanshan Wang, et al.
Published: (2025-08-01)

Factors associated with parental acceptance of the HPV vaccine in girls from metropolitan Lima, Peru
by: Valeria Juárez-Leon, et al.
Published: (2025-07-01)

THE ROLE OF HUMAN PAPILLOMAVIRUS IN DEVELOPMENT OF OROPHARYNGEAL CANCER
by: A. I. Stukan, et al.
Published: (2016-10-01)

Willingness to pay and preference for HPV vaccine among parents in China: A study based on a multi-center cross-sectional survey
by: Weihua Luo, et al.
Published: (2025-12-01)

PECTORALIS FLAP REPAIR OF DEFECT IN THE SURGICAL TREATMENT OF LOCALLY ADVANCED AND RECURRENT OROPHARYNGEAL CANCER
by: D. V. Sikorsky, et al.
Published: (2015-04-01)

EXPEDIENCY OF TEMPORAL TRACHEOSTOMY IN PATIENTS SURGICALLY TREATED FOR DISCONTINUITY OF THE MANDIBULAR ARCH
by: D. V. Sikorsky, et al.
Published: (2015-04-01)

Bioinformatics analysis of laryngeal squamous cell carcinoma based on the high infection rate of HPV in Northwest China
by: Fan Guo, et al.
Published: (2025-08-01)

General practitioners’ recommendation of HPV vaccination to adolescents aged 11–14 may be gender-biased as suggested by a qualitative study in France
by: Laura X. Gil Sánchez, et al.
Published: (2025-07-01)

Applying the technology acceptance model to examine factors influencing chatbot use in HPV prevention education among nursing students
by: Ching-Yi Lai, et al.
Published: (2025-07-01)

Improving Communication and Management Following a Positive Home HPV Self-Sampling Result: Comparing Intervention Strategies Between the HOME and STEP Trials
by: Jasmin A. Tiro, et al.
Published: (2025-01-01)

Tanzanian women´s knowledge about Cervical Cancer and HPV and their prevalence of positive VIA cervical screening results. Data from a Prevention and Awareness Campaign in Northern Tanzania, 2017 – 2019
by: Antje Henke, et al.
Published: (2021-01-01)

A rigorous exploration of anal HPV genotypes using a next‐generation sequencing (NGS) approach in HIV‐infected men who have sex with men at risk for developing anal cancer
by: Chandrika J. Piyathilake, et al.
Published: (2020-01-01)

CHOOSING OPTIONS OF SURGICAL TREATMENT FOR RECCURENT OROPHARYNGEAL CANCER
by: I. A. Zaderenko, et al.
Published: (2017-06-01)

Composite dietary antioxidant index and HPV infection from single and mixed associations to SHAP-interpreted machine learning predictions
by: Pei Zhang
Published: (2025-07-01)

SARS-CoV-2 infection heightens the risk of developing HPV-related carcinoma in situ and cancer
by: Yu-Hsiang Shih, et al.
Published: (2025-08-01)

ENHANCING VACCINAL PREVENTION OF THE HUMAN PAPILLOMA VIRAL (HPV) INFECTION: PROTECTING PEOPLE OF DIFFERENT AGE AND SEX FROM A RANGE OF HPV-ASSOCIATED DISEASES
by: M. G. Galitskaya, et al.
Published: (2013-01-01)

Third-person effects of HPV vaccination news: Exploring the relationships among media exposure, presumed media influence, and Chinese female college students’ behavioral intentions
by: Wenhui Liang, et al.
Published: (2025-12-01)

Social Ecological Influences on HPV Vaccination Among Cape Verdean Immigrants in the U. S.: A Qualitative Study
by: Ana Cristina Lindsay, et al.
Published: (2025-06-01)

Exponential uptake of HPV self-collected cervical screening testing 2 years since universal availability in Victoria, Australia
by: Alvin Lee, et al.
Published: (2025-07-01)

Barriers and enablers of HPV vaccination among caregivers of school-age girls in resource-limited regions of Western Sichuan, China: a mixed-methods study
by: Qiwen Zhang, et al.
Published: (2025-08-01)

THE ANALYSIS OF STATISTICAL DATA ON MALIGNANT NEOPLASMS ASSOCIATED WITH HUMAN P APILLOMAVIRUS
by: A. A. Kostin, et al.
Published: (2016-03-01)

Multi‐omics profiling identifies TNFRSF18 as a novel marker of exhausted CD8⁺ T cells and reveals tumour‐immune dynamics in colorectal cancer
by: Tengfei Jia, et al.
Published: (2025-08-01)

Predictive value of vaginal lactic acid bacteria changes on occurrence of HR-HPV-infected cervical intraepithelial neoplasia and construction and validation of nomogram model
by: Ying Huang, et al.
Published: (2025-07-01)

Detection of High-Risk Human Papillomavirus in Bladder Cancer: An Exploratory Study from a UK-Based Population
by: Mohammed Yahya Ahmed, et al.
Published: (2025-06-01)

-->